Doebele
Christian Doebele, Freiburg DE
Patent application number | Description | Published |
---|---|---|
20100175975 | Device with at least one control element - The invention relates to a device with at least one control element, which is positioned in a device housing for the device, such that the control element is designed as a snap disk, which is made of metal, and such that the snap disk has a rim which is connected to the device housing through material engagement and which forms a seal between the device housing and the control element, such that an area of the snap disk that borders the rim is designed as a reversibly deformable uncoupling area. | 07-15-2010 |
Eric Doebele, Seattle, WA US
Patent application number | Description | Published |
---|---|---|
20140236935 | Service Provider Matching - Embodiments that relate to matching a requester with a service provider are disclosed. In one example, a method for matching a requester with a service provider that provides services in a category may include receiving from the requester a search request including the category. At least one social network connection between the requester and an endorser of the service provider is identified. The method includes determining that the endorser has at least one endorsement connection with the service provider. Based on the social network connection and the endorsement connection, the requester is matched with the service provider. Based on matching the requester with the service provider, service provider information corresponding to the service provider is provided to a requester computing device. | 08-21-2014 |
Robert C. Doebele, Denver, CO US
Patent application number | Description | Published |
---|---|---|
20150218652 | METHODS FOR DIAGNOSIS AND TREATMENT OF CANCER - Disclosed are markers, methods and assay systems for the identification of patients suspected of having lung cancer and/or cancer patients who are predicted to respond, or not respond to the therapeutic administration of specific chemotherapeutic regimens. Particularly, the invention provides a testing paradigm based on tumor cell samples to select cancer patients who will benefit from chemotherapy including one or more kinase inhibitor(s), as well as a paradigm to select cancer patients who will not benefit from such chemotherapy regimen. | 08-06-2015 |